Aptevo Therapeutics Inc.
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.31M | -5.10M | -5.88M | -6.83M | -5.90M |
| Total Depreciation and Amortization | 71.00K | 84.00K | 91.00K | 106.00K | 116.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.00K | 149.00K | 273.00K | 719.00K | 358.00K |
| Change in Net Operating Assets | 554.00K | -354.00K | -634.00K | -642.00K | 176.00K |
| Cash from Operations | -5.76M | -5.22M | -6.15M | -6.65M | -5.25M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 6.72M | 4.91M | 3.97M | -- | 3.05M |
| Repurchase of Common Stock | 0.00 | 0.00 | -1.00K | -- | -2.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -3.00K | -- |
| Cash from Financing | 6.72M | 4.91M | 3.97M | -3.00K | 3.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 961.00K | -313.00K | -2.18M | -6.65M | -2.21M |